GENEXINE
Genexine is a clinical stage biotechnology company focused on the development and commercialization of innovative immunotherapeutics and next generation novel long-acting biologics. Our goal is to bring to patients medicines that will transform their lives.
GENEXINE
Industry:
Biotechnology Health Care Life Science Medical
Founded:
1999-06-08
Address:
Seongnam, Kyonggi-do, South Korea
Country:
South Korea
Website Url:
http://www.genexine.com
Total Employee:
101+
Status:
Active
Contact:
+82316283200
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Google Tag Manager Google Universal Analytics Global Site Tag Mobile Non Scaleable Content Nginx
Similar Organizations
Reset Pharmaceuticals
Reset Pharma is a biotechnology company that focuses on the development and commercialization of novel psychedelic treatments.
Current Employees Featured
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2020-12-14 | ToolGen | Genexine investment in Corporate Round - ToolGen | N/A |
| 2017-03-23 | I-Mab Biopharma | Genexine investment in Series B - I-Mab Biopharma | 150 M USD |
Key Employee Changes
| Date | New article |
|---|---|
| 2022-05-24 | Genexine Appoints Industry Veteran Neil Warma as Chief Executive Officer to Accelerate Global Growth, Product Commercialization and Innovation |
Official Site Inspections
http://www.genexine.com Semrush global rank: 6.68 M Semrush visits lastest month: 874
- Host name: 210.114.6.138
- IP address: 210.114.6.138
- Location: South Korea
- Latitude: 37.5112
- Longitude: 126.9741
- Timezone: Asia/Seoul
More informations about "Genexine"
GENEXINE Genexine,
Genexine is a leading biopharmaceutical company focused on discovering, developing and commercializing first and best-in-class immunotherapies for cancer and antibody therapies for …See details»
Genexine
Genexine is a leading biopharmaceutical company focused on developing innovative therapies for cancer, rare diseases, and biobetter treatments. With a foundation rooted in continuous technological innovation and a deep respect …See details»
Genexine
Before joining Genexine, Jaehyun worked at LG Chem, Samsung Advanced Institute of Technology, and Trillium Therapeutics, a clinical-stage immunotherapy drug development company, where he secured expertise in …See details»
Genexine
Genexine’s First-in-Class Therapeutic DNA Vaccine Shows Significant Potential to Extend Survival in Late-Stage Cervical Cancer. Sep 23, 2022. Genexine selected for Late-Breaking Oral Presentation of Phase 2 Study of GX-188E …See details»
Genexine, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore Genexine, Inc. with its drug pipeline, therapeutic area, technology platform, 44 clinical trials, 28 news, and 41 literature, Disease Domain:Immune System ...See details»
Genexine - Crunchbase Company Profile & Funding
Genexine is located in Seongnam, Kyonggi-do, South Korea. Who invested in Genexine? Genexine has 2 investors including IMM Private Equity and Hyundai Venture Investment Corporation. When was the last funding round for …See details»
Genexine
Dr. Kim jointed Genexine in November 2018 as professional of Bio Research Institute and is responsible for strengthening the development capability of R&D pipeline. He has more than 35 years of R&D experience in the …See details»
Genexine Company Profile - Office Locations, Competitors ... - Craft
Oct 29, 2024 Genexine has 5 employees across 2 locations and ₩4.43 b in annual revenue in FY 2023. See insights on Genexine including office locations, competitors, revenue, financials, …See details»
Genexine - Devex
Learn more about Genexine's jobs, projects, latest news, contact information and geographical presence. Genexine is a clinical stage biotechnology company focused on the development …See details»
Genexine Inc Company Profile - GlobalData
Genexine develops products for various therapeutic areas such as orphans, cancers and also immune disorders. The company uses hybrid Fc technology platform for the discovery of a …See details»
Genexine
CEO Message Genexine, Guide to a Healthier tomorrow Leading K-bio company based on proprietary platform technologies ... We are excited about the potential and the future of …See details»
Genexine, Inc. - LinkedIn
Genexine, Inc. | 1,215 followers on LinkedIn. Genexine has robust R&D pipelines in clinical and pre-clinical stages based on long-acting Fc-fusion technology and therapeutic DNA vaccine …See details»
Genexine
Genexine’s vision of treating patients and improving their quality of life is being practically realized owing to faster and more accurate drug development based on clinical planning and …See details»
Genexine
Genexine has established and operates a board of directors and committees to develop a sound and transparent governance structure. In addition, Genexine's ethical management and hotline …See details»
Genexine - Funding, Financials, Valuation & Investors - Crunchbase
Jan 1, 2006 Genexine has raised 2 rounds. Their latest funding was raised on Jan 1, 2006 from a Venture - Series Unknown round. Genexine is funded by 2 investors. IMM Private Equity and …See details»
Genexine
Any audit or investigation is operated independently to the organization and the auditor will faithfully investigate all matters and ensure they are managed appropriately with anonymity …See details»
Genexine
With GX-P1 and GX-P10, Genexine is pursuing a fundamental approach to the disease-causing immune cells in which the auto-reactive immune cells are controlled by suppressive PD-1/PD …See details»
Genexine
Genexine’s Bio Research Institute focus on novel & first in class products. Established facility and CMC experts . Facility · Small scale(3L, 15L) · Large Scale(50L, 200L) · Analysis : LC-MS & …See details»
Press Releases - Genexine
Feb 3, 2023 Genexine signed MOU with Global Vaccine Leading Technology Center. Jan 7, 2023. PHARMNEWS. Genexine Bio Innovation Park Ceremony (20220525) Jan 7, 2023. …See details»